Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms

Sigurjonsdottir, G; De Marchi, T; Ehinger, A; Hartman, J; Bosch, A; Staaf, J; Killander, F; Nimeus, E

Nimeus, E (通讯作者)，Lund Univ, Dept Clin Sci Lund, Div Oncol, Lund, Sweden.;Nimeus, E (通讯作者)，Lund Univ, Dept Clin Sci Lund, Divison Surg, Solvegatan 19-BMC I12, S-22184 Lund, Sweden.;Nimeus, E (通讯作者)，Skane Univ Hosp, Dept Surg, Malmo, Sweden.

BREAST CANCER RESEARCH, 2023; 25 (1):

Abstract

Background Immunohistochemical (IHC) PD-L1 expression is commonly employed as predictive biomarker for checkpoint inhibitors in triple-negative breast......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索